Home 9 Meters Biopharma

9 Meters Biopharma

In operation
IPO Delisting
Gastrointestinal Disease Biologics Developer
Basic
Enterprise Profile

Basic Information

9 Meters Biopharma is a gastrointestinal platform company focused on rare diseases and unmet needs of patients. The company’s pipeline includes drug candidates for short bowel syndrome and celiac disease. 9 Meters Biopharma is led by a strong management team with a history of bringing novel therapies to market, holds global rights to its products, and owns more than 150 patents worldwide.
9 Meters Biopharma Inc.
NorthCarolina,United States of America
15~50 people
January 01, 2012
--
info@9meters.com

Enterprise Profile

Industrial Sector
New Drug Development Manufacture of Biological Pharmaceutical Products
Technology
Biotechnology
Concept
Department of Gastroenterology Digestive System Diseases Therapeutic Products
Application Scenarios
Innovative Drugs Biological Products Monoclonal Antibody